butyrylcarnitine has been researched along with palmitic acid in 2 studies
Studies (butyrylcarnitine) | Trials (butyrylcarnitine) | Recent Studies (post-2010) (butyrylcarnitine) | Studies (palmitic acid) | Trials (palmitic acid) | Recent Studies (post-2010) (palmitic acid) |
---|---|---|---|---|---|
29 | 2 | 13 | 6,794 | 159 | 2,458 |
Protein | Taxonomy | butyrylcarnitine (IC50) | palmitic acid (IC50) |
---|---|---|---|
Toll-like receptor 2 | Homo sapiens (human) | 5 | |
Fatty acid-binding protein, intestinal | Homo sapiens (human) | 1.7 | |
Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 0.93 | |
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 8.8 | |
Fatty acid-binding protein 5 | Homo sapiens (human) | 1.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bali, D; Gregersen, N; Koeberl, DD; Liu, HM; Matern, D; Millington, DS; Stevens, RD; Young, SP | 1 |
Furey, A; Liu, M; Rahman, P; Randell, EW; Sun, G; Werdyani, S; Zhai, G; Zhang, H | 1 |
2 other study(ies) available for butyrylcarnitine and palmitic acid
Article | Year |
---|---|
A comparison of in vitro acylcarnitine profiling methods for the diagnosis of classical and variant short chain acyl-CoA dehydrogenase deficiency.
Topics: Acyl-CoA Dehydrogenase; Butyric Acid; Butyryl-CoA Dehydrogenase; Carbon Isotopes; Carnitine; Deuterium; DNA Mutational Analysis; Fibroblasts; Heterozygote; Homozygote; Humans; Malonates; Mutation, Missense; Palmitic Acid; Palmitoylcarnitine; Polymorphism, Genetic; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Spiro Compounds | 2003 |
Endotypes of primary osteoarthritis identified by plasma metabolomics analysis.
Topics: Aged; Arginine; Body Mass Index; Carnitine; Case-Control Studies; Coronary Disease; Diabetes Mellitus; Factor Analysis, Statistical; Fasting; Female; Humans; Logistic Models; Lysophosphatidylcholines; Male; Metabolomics; Muscle Weakness; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoporosis; Palmitic Acid; Prevalence; Quality Control; Wasting Syndrome | 2021 |